{"id":"https://openalex.org/W2035325895","doi":"https://doi.org/10.1089/cap.1997.7.65","title":"Attenuation of Antipsychotic-Induced Hyperprolactinemia with Clozapine","display_name":"Attenuation of Antipsychotic-Induced Hyperprolactinemia with Clozapine","publication_year":1997,"publication_date":"1997-01-01","ids":{"openalex":"https://openalex.org/W2035325895","doi":"https://doi.org/10.1089/cap.1997.7.65","mag":"2035325895","pmid":"https://pubmed.ncbi.nlm.nih.gov/9192542"},"language":"en","primary_location":{"id":"doi:10.1089/cap.1997.7.65","doi":"https://doi.org/10.1089/cap.1997.7.65","is_oa":false,"landing_page_url":"https://doi.org/10.1089/cap.1997.7.65","pdf_url":null,"source":{"id":"https://openalex.org/S198272637","display_name":"Journal of Child and Adolescent Psychopharmacology","issn_l":"1044-5463","issn":["1044-5463","1557-8992"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Child and Adolescent Psychopharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5009277492","display_name":"Mark T. Bunker","orcid":"https://orcid.org/0000-0001-5871-0687","observed_orcids":["https://orcid.org/0000-0001-5871-0687"]},"institutions":[{"id":"https://openalex.org/I75421653","display_name":"University of Missouri\u2013Kansas City","ror":"https://ror.org/01w0d5g70","country_code":"US","type":"education","lineage":["https://openalex.org/I75421653"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"MARK T. BUNKER","raw_affiliation_strings":["Division of Pharmacy Practice, School of Pharmacy, University of Missouri-Kansas City 64108, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pharmacy Practice, School of Pharmacy, University of Missouri-Kansas City 64108, USA","institution_ids":["https://openalex.org/I75421653"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022754854","display_name":"Patricia A. Marken","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I75421653","display_name":"University of Missouri\u2013Kansas City","ror":"https://ror.org/01w0d5g70","country_code":"US","type":"education","lineage":["https://openalex.org/I75421653"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"PATRICIA A. MARKEN","raw_affiliation_strings":["","University of Missouri at Kansas City"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"","institution_ids":[]},{"raw_affiliation_string":"University of Missouri at Kansas City","institution_ids":["https://openalex.org/I75421653"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041513445","display_name":"Mark E. Schneiderhan","orcid":"https://orcid.org/0000-0002-4239-3354","observed_orcids":["https://orcid.org/0000-0002-4239-3354"]},"institutions":[{"id":"https://openalex.org/I75421653","display_name":"University of Missouri\u2013Kansas City","ror":"https://ror.org/01w0d5g70","country_code":"US","type":"education","lineage":["https://openalex.org/I75421653"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"MARK E. SCHNEIDERHAN","raw_affiliation_strings":["","University of Missouri at Kansas City"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"","institution_ids":[]},{"raw_affiliation_string":"University of Missouri at Kansas City","institution_ids":["https://openalex.org/I75421653"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5026168258","display_name":"Valerie Ruehter","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I75421653","display_name":"University of Missouri\u2013Kansas City","ror":"https://ror.org/01w0d5g70","country_code":"US","type":"education","lineage":["https://openalex.org/I75421653"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"VALERIE L. RUEHTER","raw_affiliation_strings":["","University of Missouri at Kansas City"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"","institution_ids":[]},{"raw_affiliation_string":"University of Missouri at Kansas City","institution_ids":["https://openalex.org/I75421653"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I75421653"],"apc_list":null,"apc_paid":null,"fwci":1.0176,"has_fulltext":false,"cited_by_count":22,"citation_normalized_percentile":{"value":0.76788262,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"7","issue":"1","first_page":"65","last_page":"69"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10832","display_name":"Pituitary Gland Disorders and Treatments","score":0.0013000000035390258,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/clozapine","display_name":"clozapine","score":0.8930000066757202},{"id":"https://openalex.org/keywords/antipsychotic-induced-hyperprolactinemia","display_name":"antipsychotic-induced hyperprolactinemia","score":0.9449999928474426},{"id":"https://openalex.org/keywords/atypical-antipsychotics","display_name":"atypical antipsychotics","score":0.8899999856948853},{"id":"https://openalex.org/keywords/typical-antipsychotics","display_name":"typical antipsychotics","score":0.824999988079071},{"id":"https://openalex.org/keywords/thioridazine","display_name":"thioridazine","score":0.8270000219345093},{"id":"https://openalex.org/keywords/haloperidol","display_name":"haloperidol","score":0.9869999885559082},{"id":"https://openalex.org/keywords/fluphenazine","display_name":"fluphenazine","score":0.9990000128746033},{"id":"https://openalex.org/keywords/bromocriptine","display_name":"bromocriptine","score":0.9639999866485596},{"id":"https://openalex.org/keywords/galactorrhea","display_name":"galactorrhea","score":0.9860000014305115},{"id":"https://openalex.org/keywords/amenorrhea","display_name":"amenorrhea","score":0.9990000128746033},{"id":"https://openalex.org/keywords/adolescents","display_name":"adolescents","score":0.5019999742507935},{"id":"https://openalex.org/keywords/serum-prolactin","display_name":"serum prolactin","score":0.6579999923706055}],"concepts":[{"id":"https://openalex.org/C2780864610","wikidata":"https://www.wikidata.org/wiki/Q221361","display_name":"Clozapine","level":3,"score":0.9204937219619751},{"id":"https://openalex.org/C2776856834","wikidata":"https://www.wikidata.org/wiki/Q413581","display_name":"Bromocriptine","level":4,"score":0.7773219347000122},{"id":"https://openalex.org/C2776978879","wikidata":"https://www.wikidata.org/wiki/Q58376","display_name":"Fluphenazine","level":4,"score":0.7531008720397949},{"id":"https://openalex.org/C2780688371","wikidata":"https://www.wikidata.org/wiki/Q58375","display_name":"Thioridazine","level":3,"score":0.7508218884468079},{"id":"https://openalex.org/C2777863693","wikidata":"https://www.wikidata.org/wiki/Q278515","display_name":"Galactorrhea","level":4,"score":0.7148578763008118},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.7033758163452148},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5825082063674927},{"id":"https://openalex.org/C2780948584","wikidata":"https://www.wikidata.org/wiki/Q251347","display_name":"Haloperidol","level":3,"score":0.5689302086830139},{"id":"https://openalex.org/C2778058571","wikidata":"https://www.wikidata.org/wiki/Q334655","display_name":"Amenorrhea","level":3,"score":0.5454330444335938},{"id":"https://openalex.org/C2777845345","wikidata":"https://www.wikidata.org/wiki/Q144085","display_name":"Pimozide","level":4,"score":0.5133275389671326},{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.4352865219116211},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.4279954731464386},{"id":"https://openalex.org/C2776921671","wikidata":"https://www.wikidata.org/wiki/Q758295","display_name":"Atypical antipsychotic","level":4,"score":0.4242861866950989},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.36545515060424805},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.35898399353027344},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.3549231290817261},{"id":"https://openalex.org/C2779064019","wikidata":"https://www.wikidata.org/wiki/Q66590068","display_name":"Prolactin","level":3,"score":0.3460935354232788},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.33566445112228394},{"id":"https://openalex.org/C2778775820","wikidata":"https://www.wikidata.org/wiki/Q407972","display_name":"Chlorpromazine","level":2,"score":0.24195262789726257},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.22793960571289062},{"id":"https://openalex.org/C2779234561","wikidata":"https://www.wikidata.org/wiki/Q11995","display_name":"Pregnancy","level":2,"score":0.1465819776058197},{"id":"https://openalex.org/C71315377","wikidata":"https://www.wikidata.org/wiki/Q11364","display_name":"Hormone","level":2,"score":0.05738729238510132},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C87355193","wikidata":"https://www.wikidata.org/wiki/Q411","display_name":"Astrobiology","level":1,"score":0.0},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000568","descriptor_name":"Amenorrhea","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D001971","descriptor_name":"Bromocriptine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D003024","descriptor_name":"Clozapine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005476","descriptor_name":"Fluphenazine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D005687","descriptor_name":"Galactorrhea","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D006220","descriptor_name":"Haloperidol","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006966","descriptor_name":"Hyperprolactinemia","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D006966","descriptor_name":"Hyperprolactinemia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D011388","descriptor_name":"Prolactin","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D011618","descriptor_name":"Psychotic Disorders","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D013881","descriptor_name":"Thioridazine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1089/cap.1997.7.65","doi":"https://doi.org/10.1089/cap.1997.7.65","is_oa":false,"landing_page_url":"https://doi.org/10.1089/cap.1997.7.65","pdf_url":null,"source":{"id":"https://openalex.org/S198272637","display_name":"Journal of Child and Adolescent Psychopharmacology","issn_l":"1044-5463","issn":["1044-5463","1557-8992"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Child and Adolescent Psychopharmacology","raw_type":"journal-article"},{"id":"pmid:9192542","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9192542","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of child and adolescent psychopharmacology","raw_type":"Case Reports"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Case Report","id":"https://openalex.org/study-designs/case-report"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":1,"referenced_works":["https://openalex.org/W2333694141"],"related_works":["https://openalex.org/W7218038366","https://openalex.org/W2049164408","https://openalex.org/W2142811031","https://openalex.org/W100818451","https://openalex.org/W2092126524","https://openalex.org/W2014100757","https://openalex.org/W1004984661","https://openalex.org/W3003286629","https://openalex.org/W135056825","https://openalex.org/W4226080589"],"abstract_inverted_index":{"Hyperprolactinemia":[0],"is":[1,13],"a":[2,21],"well-known":[3],"consequence":[4],"of":[5,23,58,128],"conventional":[6,139],"antipsychotic":[7,11],"therapy.":[8],"The":[9],"atypical":[10,129],"clozapine":[12,31,96],"reported":[14],"to":[15,30,95,121],"lack":[16],"this":[17],"effect.":[18],"We":[19,124],"describe":[20],"case":[22],"attenuated":[24],"serum":[25,112],"prolactin":[26,113],"levels":[27],"after":[28,72,115],"conversion":[29],"therapy":[32],"in":[33,76],"an":[34,73],"adolescent.":[35],"A":[36],"13-year-old":[37],"female":[38],"patient":[39,92],"developed":[40],"hyperprolactinemia":[41,81,136],"with":[42,60],"galactorrhea":[43],"and":[44,65,80,86,109],"amenorrhea":[45],"while":[46],"receiving":[47],"thioridazine":[48,83],"300":[49],"mg":[50,63,69,85,89,102],"daily.":[51,70],"These":[52],"symptoms":[53,79],"continued":[54],"throughout":[55],"3":[56],"years":[57],"treatment":[59],"haloperidol":[61],"10":[62,68],"daily":[64,104],"then":[66],"fluphenazine":[67],"Subsequently,":[71],"incomplete":[74],"improvement":[75],"her":[77,106,111],"psychiatric":[78,107],"on":[82],"150":[84,101],"bromocriptine":[87,118],"15":[88],"daily,":[90],"the":[91],"was":[93,119],"changed":[94],"at":[97],"age":[98],"16.":[99],"Clozapine":[100],"twice":[103],"improved":[105],"status":[108],"corrected":[110],"concentrations":[114],"2":[116],"weeks;":[117],"able":[120],"be":[122],"discontinued.":[123],"recommend":[125],"systematic":[126],"evaluation":[127],"neuroleptics":[130],"as":[131],"alternative":[132],"treatments":[133],"for":[134],"refractory":[135],"induced":[137],"by":[138],"antipsychotics.":[140]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2016,"cited_by_count":2},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}